What is CCS Associates?
Founded in 1985 by Dr. Caroline C. Sigman, CCS Associates, Inc. (CCSA) operates as a premier scientific research consulting firm. The organization provides high-level technical and support services, focusing on clinical research, preclinical study design, and chemical information sciences. By bridging the gap between complex bioinformatics and translational science, CCSA serves as a vital partner for government agencies and pharmaceutical developers. Their expertise in managing master databases of chemical information and navigating the intricacies of drug development pipelines positions them as a cornerstone of modern medical research infrastructure.
How much funding has CCS Associates raised?
CCS Associates has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CCS Associates
PPP
Public-Private Partnership
What's next for CCS Associates?
With this major enterprise-level funding, CCS Associates is well-positioned to expand its service offerings and enhance its technological capabilities in bioinformatics. The firm is expected to leverage this capital to deepen its engagement with federal research initiatives and private biotech innovators, potentially accelerating the development of new clinical trial methodologies. By maintaining its focus on high-impact scientific advisory, CCSA is poised to capitalize on the increasing demand for data-driven drug discovery and regulatory support, ensuring long-term growth and continued influence in the global life sciences sector.
See full CCS Associates company page
